Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Combined Chemotherapy Protocols
  • BRCA1 Protein
  • BRCA2 Protein
  • Germ-Line Mutation
  • Neoplasm Recurrence, Local
  • Pancreatic Neoplasms

abstract

  • In this retrospective analysis, the prognosis of surgically resectable BRCA-associated PDAC is no different than that of sporadic PDAC from the same institution. The role of platinum-based adjuvant therapy in this setting requires prospective investigation.

publication date

  • March 14, 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5355924

Digital Object Identifier (DOI)

  • 10.1038/bjc.2017.19

PubMed ID

  • 28183138

Additional Document Info

start page

  • 697

end page

  • 702

volume

  • 116

number

  • 6